查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1571569

口蹄疫疫苗市場規模：佔有率，趨勢分析報告：按動物、疫苗、通路、地區、細分市場預測，2024-2030年

Foot And Mouth Disease Vaccine Market Size, Share & Trends Analysis Report By Animal (Cattle, Sheep & Goat, Swine), By Vaccine (Modified/Attenuated Live), By Distribution Channel, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

口蹄疫疫苗市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球口蹄疫疫苗市場規模將達到38.8億美元，2024年至2030年複合年成長率為8.2%。

口蹄疫發病率的增加以及對畜產品國際貿易的社會經濟影響正在推動口蹄疫疫苗的需求。此外，由於疫苗的保存期限較短，因此往往會被重複購買。

這個市場競爭非常激烈，各政府機構紛紛介入大量購買疫苗。過去幾十年來，世界牲畜數量一直在動態成長。在開發中國家，對畜產品的需求不斷增加，導致人們對牲畜健康的關注日益增加。對畜產品日益成長的需求徹底改變了全球畜牧業。此外，生活方式改變和人口成長導致的飲食偏好改變等因素預計將推動對畜牧產品的需求。

由於油基疫苗的高效性，擴大採用油基疫苗，預計將佔據傳統疫苗的最大佔有率。現有的常規疫苗可有效預防臨床疾病，但保護時間較短。因此，需要經常接種疫苗作為預防措施。

口蹄疫疫苗市場報告亮點

  • 去活化（去活化）疫苗細分市場佔據主導地位，2023 年市場佔有率為 53.0%。
  • 牛在 2023 年佔據市場主導地位，市場佔有率為 53.5%，預計在預測期內將以最快的複合年成長率成長。
  • 預計生豬市場在預測期內將以顯著的複合年成長率成長。這是由於豬肉的需求不斷增加，因為豬肉是世界上許多開發中國家的良好蛋白質來源和收入來源。
  • 2023年，亞太地區口蹄疫疫苗市場將以48.2%的銷售佔有率佔據主導地位。

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章 口蹄疫疫苗市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 口蹄疫疫苗市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 口蹄疫疫苗市場：動物估計與趨勢分析

  • 細分儀表板
  • 口蹄疫疫苗市場：2023 年和 2030 年動物變化分析
  • 牛
  • 綿羊和山羊
  • 豬
  • 其他

第5章 口蹄疫疫苗市場：疫苗預估及趨勢分析

  • 細分儀表板
  • 口蹄疫疫苗市場：2023年及2030年疫苗波動分析
  • 減毒/活細菌
  • 惰性（死菌）
  • 其他疫苗（DNA疫苗、胜肽疫苗）

第6章 口蹄疫疫苗市場：通路估算及趨勢分析

  • 細分儀表板
  • 口蹄疫疫苗市場：2023年及2030年通路波動分析
  • 動物醫院/診所
  • 政府機構
  • 其他

第7章 口蹄疫疫苗市場：區域估算及趨勢分析

  • 2023年及2030年按地區分類的口蹄疫疫苗市場佔有率
  • 歐洲
    • 俄羅斯
    • 法國
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 韓國
    • 印尼
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 埃及
    • 土耳其

第8章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Merck &Co., Inc.
    • Biogenesis Bago
    • Zoetis Inc.
    • Boehringer Ingelheim International GmbH
    • Indian Immunologicals Limited
    • Bayer AG
    • Hester Biosciences Limited
    • Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
    • Brilliant Bio Pharma Limited
    • Biovet Private Ltd
簡介目錄
Product Code: GVR-1-68038-656-1

Foot And Mouth Disease Vaccine Market Growth & Trends:

The global foot and mouth disease vaccine market size is expected to reach USD 3.88 billion by 2030, registering a CAGR of 8.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. An increase in the incidence of FMD and their socioeconomic impact over international trade of animal products are propelling the demand for FMD vaccines. In addition, effectiveness for a lower time period propels the repeat purchase of vaccines.

This market is highly competitive and various government entities intervene for bulk purchase of vaccines. There has been dynamic growth in the global livestock population over the past few decades. In developing countries, the demand for livestock products is increasing owing to which concern for healthy livestock population is increasing. Rising demand for animal products has revolutionized the global livestock production. In addition, factors such as a change in food preferences owing to changing lifestyles coupled with a growing population are anticipated to boost the demand for livestock products.

Increased adoption of oil-based vaccines owing to their higher efficacy is expected to contribute to the largest share of conventional vaccines. Available conventional vaccines are effective in the prevention of clinical diseases; however, they offer protection for a shorter duration. Hence, as a prophylactic measure, frequent vaccination becomes necessary.

Foot And Mouth Disease Vaccine Market Report Highlights:

  • The inactivated (killed) vaccine segment dominated the market and accounted for a market share of 53.0% in 2023.
  • Cattle dominated the market with a market share of 53.5% in 2023 and is expected to grow at the fastest CAGR over the forecast period.
  • The swine segment is expected to grow at a significant CAGR over the forecast period. It is attributed to the rising demand for pork as it is a good source of protein and income source in many developing countries across the world.
  • Asia Pacific foot & mouth disease vaccine market dominated with a revenue share of 48.2% in 2023 owing to the growing livestock population and high prevalence of FMD in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Foot & Mouth Disease Vaccine Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Foot & Mouth Disease Vaccine Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Foot & Mouth Disease Vaccine Market: Animal Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Foot & Mouth Disease Vaccine Market: Animal Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Cattle
    • 4.3.1. Cattle Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Sheep and Goat
    • 4.4.1. Sheep and Goat Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Swine
    • 4.5.1. Swine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Foot & Mouth Disease Vaccine Market: Vaccine Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Foot & Mouth Disease Vaccine Market: Vaccine Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Modified/ Attenuated Live
    • 5.3.1. Modified/ Attenuated Live Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Inactivated (Killed)
    • 5.4.1. Inactivated (Killed) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Other Vaccines (DNA vaccines, Peptide vaccines)
    • 5.5.1. Other Vaccines (DNA vaccines, Peptide vaccines) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Foot & Mouth Disease Vaccine Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Foot & Mouth Disease Vaccine Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Veterinary Hospitals & Clinics
    • 6.3.1. Veterinary Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Government Institutions
    • 6.4.1. Government Institutions Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Foot & Mouth Disease Vaccine Market: Regional Estimates & Trend Analysis

  • 7.1. Foot & Mouth Disease Vaccine Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. Europe
    • 7.2.1. Europe Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. Russia
      • 7.2.2.1. Russia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. France
      • 7.2.3.1. France Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Asia Pacific
    • 7.3.1. Asia Pacific Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. Japan
      • 7.3.2.1. Japan Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. China
      • 7.3.3.1. China Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. India
      • 7.3.4.1. India Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. South Korea
      • 7.3.5.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Indonesia
      • 7.3.6.1. Indonesia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. South Korea
      • 7.3.7.1. South Korea Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Thailand
      • 7.3.8.1. Thailand Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Latin America
    • 7.4.1. Latin America Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. Brazil
      • 7.4.2.1. Brazil Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Argentina
      • 7.4.3.1. Argentina Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Middle East and Africa
    • 7.5.1. Middle East and Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. South Africa
      • 7.5.2.1. South Africa Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Saudi Arabia
      • 7.5.3.1. Saudi Arabia Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.4. UAE
      • 7.5.4.1. Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.5. Kuwait
      • 7.5.5.1. Kuwait Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.6. Egypt
      • 7.5.6.1. Egypt Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.7. Turkey
      • 7.5.7.1. Turkey Foot & Mouth Disease Vaccine Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Merck & Co., Inc.
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. Biogenesis Bago
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Zoetis Inc.
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Boehringer Ingelheim International GmbH
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Indian Immunologicals Limited
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Bayer AG
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Hester Biosciences Limited
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. Inner Mongolia Biwei Antai Biotechnology Co., Ltd.
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Brilliant Bio Pharma Limited
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Biovet Private Ltd
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives